In a finding that could inform therapeutic targets for Alzheimer’s and Parkinson’s disease, a team of Brown University neuroscientists reports on a mechanism of degeneration for the locus coeruleus region of the brain.
The study is an example of how brain imaging technology — in this case developed by researchers at Brown University — can be adapted to advance knowledge of brain processes and prompt new questions about behavior.
Improved understanding of a neural pathway connecting light-sensitive cells in the retina with the cortical brain regions involved in mood and cognition has implications for the development of treatments for mood disorders.
A new study associated with the BrainGate consortium offered significant clues about how humans learn and form long-term memories; the findings could provide insights for developers of assistive tools for people with paralysis.
The Brown Corporation authorized a process to select an architect and launch a full programming phase for the building, a critical step in a long-held vision to create new laboratory space for cutting-edge life sciences research.
Led by principal investigator John Sedivy, a multi-university effort will build on recent discoveries about mechanisms of aging to understand causes and potential treatments for neurodegenerative diseases.
After witnessing challenges faced by childhood friends, Glenn is researching the neurobiological underpinnings of alcohol and substance abuse disorders with the goal of enabling more effective treatments.
A five-year, $1.5 million grant from the National Institutes of Health will support Ahmed Abdelfattah’s research to shed light on brain activity, which could ultimately benefit patients facing a range of disorders.
The COBRE Center for Computational Biology of Human Disease is advancing the use of computational tools among biomedical scientists at Brown, helping them unlock new insights that could ultimately benefit patients.
New findings from a Brown research team about Christianson syndrome could eventually be used to inform therapeutic interventions for that disorder as well as for neurodegenerative conditions like Alzheimer’s disease.
Through a nine-week program organized by the Carney Institute for Brain Science, undergraduates from multiple universities learn the building blocks of computational brain science, a growing and increasingly important field.
Using a brain-computer interface, a clinical trial participant was able to create text on a computer at a rate of 90 characters per minute just by thinking about the movements involved in writing by hand.
By bringing together biomedical research and discovery with world-class physician-scientists advancing care for patients with Alzheimer’s, the center aims to accelerate the pace of development for novel treatments and cures.
In an important step toward a fully implantable intracortical brain-computer interface system, BrainGate researchers demonstrated the first human use of a wireless transmitter capable of delivering high-bandwidth neural signals.
A team led by Brown University researchers reprogrammed patient blood cells into stem cells to test treatments for Christianson syndrome, finding that treatment responses varied according to the mutations present.
In a conversation with leaders of Brown’s Carney Institute for Brain Science, two Brown neuroengineers explored how brain-computer interfaces promise to help restore movement in people with brain or spinal disorders.
The Center for Computational Brain Science at Brown’s Carney Institute for Brain Science will harness the University’s expertise in computation, cognition and systems neuroscience toward new brain health solutions.